Better adherence to bisphosphonate therapy is associated with reduced nonvertebral fracture risk

被引：0
|
作者：
Sunyecz, John A. [1 ]
Bachmann, Gloria [1 ]
Barr, Charles E. [1 ]
Silverman, Stuart [1 ]
机构：
[1] Laurel Highlands Ob Gyn, PC, Hopwood, PA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 107卷 / 04期
关键词：
D O I：
10.1097/00006250-200604001-00057
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：25S / 25S
页数：1
相关论文
共 50 条
  • [1] Adherence to bisphosphonate (BP) therapy for postmenopausal osteoporosis (PMO) is associated with a reduced risk of nonvertebral bone fracture
    Harris, S
    Silverman, S
    Siris, E
    Abbott, T
    Barr, C
    Rosen, C
    Geffen, D
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 799 - 799
  • [2] Adherence to bisphosphonate therapy is associated with decreased nonvertebral osteoporotic fracture risk.
    Silverman, S
    Siris, E
    Abbott, T
    Barr, C
    Harris, S
    Rosen, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S286 - S286
  • [3] EXTENDED BISPHOSPHONATE THERAPY NOT ASSOCIATED WITH REDUCED HIP FRACTURE RISK
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2021, 121 (04) : 47 - 47
  • [4] Greater adherence to bisphosphonate therapy is associated with greater fracture risk reduction in postmenopausal women.
    Siris, E
    Rosen, C
    Silverman, S
    Abbott, T
    Barr, C
    Harris, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S282 - S282
  • [5] Nonvertebral fracture risk reduced as soon as 6 months with risedronate therapy in postmenopausal osteoporosis
    Eastell, R
    Harrington, JT
    Boonen, S
    BONE, 2003, 32 (05) : S207 - S207
  • [6] Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: Relationship to vertebral and nonvertebral fractures from 2 US claims databases
    Siris, Ethel S.
    Harris, Steven T.
    Rosen, Clifford J.
    Barr, Charles E.
    Arvesen, James N.
    Abbott, Thomas A.
    Silverman, Stuart
    MAYO CLINIC PROCEEDINGS, 2006, 81 (08) : 1013 - 1022
  • [7] Effect of duration of teriparatide therapy on nonvertebral fracture risk
    Pohl, G
    Wang, JY
    Scheele, WH
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S234 - S234
  • [8] Adherence to bisphosphonates reduces nonvertebral fracture risk in postmenopausal osteoporosis.
    Silverman, S
    Siris, E
    Abbott, T
    Barr, C
    Harris, S
    Rosen, C
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S298 - S298
  • [9] PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE
    Chodick, G.
    Shalev, V
    Sharon, Y.
    Goldstein, I
    VALUE IN HEALTH, 2011, 14 (03) : A124 - A124
  • [10] Femoral Spontaneous fracture Associated with Bisphosphonate Therapy
    Rahgoshay, S.
    Friedman, S. M.
    Bukata, S. V.
    Caprio, T. V.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S23 - S23
12345